Eli Lilly

3 stories · following the connections

Business

Finalists Announced for 2018 Diabetes Innovation Challenge

By Nasdaq OMXApr 24, 2018, 12:10 PM UTC

Business

INVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKS

By Nasdaq OMXDec 13, 2017, 6:13 PM UTC

Business

CrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research Programs

By Nasdaq OMXNov 21, 2017, 1:00 PM UTC